Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
BioNTech SE
Merck Sharp & Dohme LLC
EpicentRx, Inc.
Alliance for Clinical Trials in Oncology
RTOG Foundation, Inc.
UNICANCER
Fuzhou General Hospital
SWOG Cancer Research Network
Alliance for Clinical Trials in Oncology
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Swami Rama Cancer Hospital and Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Gustave Roussy, Cancer Campus, Grand Paris
University College, London
National Cancer Institute (NCI)